Nurix Therapeutics appoints Arati V. Rao as chief medical officer

NRIX•2026-11-11

Nurix Therapeutics appointed Arati V. Rao as chief medical officer; she joins from Pfizer and will lead clinical development as the company advances bexobrutideg with Roche and its broader pipeline.

1. Clinical development leadership

Rao joins Nurix from Pfizer, where she most recently served as global franchise head for PF-08634404. She will lead clinical development as Nurix advances bexobrutideg with Roche and its broader pipeline.

Nurix Therapeutics appoints Arati V. Rao as chief medical officer

1. Clinical development leadership

Related News

UK watchdog demands competition remedies in $65 billion Unilever-McCormick food deal

Moomoo joins NYSE American to debut binary return options

Carlsmed target price raised to $23 from $20 by Truist Securities

Israel LiDAR supplier Innoviz's Q3 revenue falls; to cut workforce by 20%

CoreWeave, Inc.: Truist Securities cuts target price to $115 from $165